Boiron SA (EPA: BOI)

Market Cap	519.13M
Revenue (ttm)	481.71M
Net Income (ttm)	23.69M
Shares Out	17.36M
EPS (ttm)	1.36
PE Ratio	21.91
Forward PE	26.38
Dividend	1.35 (4.54%)
Ex-Dividend Date	Jun 3, 2024

Volume	2,783
Open	29.75
Previous Close	29.75
Day's Range	29.15 - 29.90
52-Week Range	29.15 - 42.80
Beta	0.46
Analysts	n/a
Price Target	n/a
Earnings Date	Mar 20, 2025

About Boiron

Boiron SA manufactures and sells homeopathic medicines in France, rest of Europe, North America, and internationally. The company offers non-proprietary homeopathic medicines and homeopathic specialties; and other healthcare products include medical devices, invitro diagnostics, dietary supplements, cosmetics, and phytotherapy. It also provides homeopathic specialties comprising Oscillococcinum to treat influenza symptoms, such as fever, chills, headaches, and aches; Stodal and Stodaline for treating coughs; Arnigel for adjunctive local treatme...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1932
• Employees: 2,810
• Stock Exchange: Euronext Paris
• Ticker Symbol: BOI

Financial Performance

In 2023, Boiron's revenue was 493.25 million, a decrease of -7.67% compared to the previous year's 534.24 million. Earnings were 35.83 million, a decrease of -19.80%.